# Distinct Cytokine Landscapes Induced by Influenza a Virus, RSV, and SARS-CoV-2 in Older Adults (65+) Using an Ex Vivo Whole Blood Stimulation Model

**Authors:** Annapina Palmieri, Ilaria Schiavoni, Eleonora Olivetta, Pasqualina Leone, Alessandra Fallucca, Anita Muglia, Angelo Carfì, Antonella Di Paola, Graziano Onder, Giorgio Fedele

PMC · DOI: 10.3390/pathogens15020139 · 2026-01-27

## TL;DR

This study compares immune responses in older adults to three respiratory viruses using a blood model and finds distinct patterns of cytokine expression.

## Contribution

The study introduces a novel ex vivo model to compare immune activation profiles in older adults against three viruses.

## Key findings

- RSV stimulation led to higher inflammatory mediator expression compared to other viruses.
- IAV and SARS-CoV-2 induced greater Type I interferon expression.
- SARS-CoV-2 uniquely increased regulatory cytokine expression.

## Abstract

Exaggerated immune responses to respiratory viruses may contribute to increased morbidity in older adults. To investigate virus-specific immune activation in this population, we developed an ex vivo whole blood stimulation model using samples from 30 healthy individuals aged ≥65 years. Whole blood was stimulated with UV-inactivated influenza A virus (IAV), respiratory syncytial virus (RSV), and SARS-CoV-2, and the expression of 22 immune-related genes was assessed by quantitative RT-PCR array. All three viruses elicited responses with marked variability across individuals, as well as differences in the magnitude and distribution of cytokine expression across stimuli. RSV stimulation was associated with relatively higher expression of inflammatory mediators, while IAV and SARS-CoV-2 induced greater expression of Type I interferon. SARS-CoV-2 also led to an increased expression of regulatory cytokines. Although individual responses varied, correlation analysis indicated coordinated gene expression within functional categories, and Uniform Manifold Approximation and Projection (UMAP) showed distinct grouping of cytokine responses by virus and function. These findings describe differential immune mRNA expression profiles in response to viral stimuli in older adults and may support future studies aimed at understanding age-related differences in host–virus interactions.

## Linked entities

- **Diseases:** SARS-CoV-2 (MONDO:0100096)

## Full-text entities

- **Genes:** IL12A (interleukin 12A) [NCBI Gene 3592] {aka CLMF, IL-12A, NFSK, NKSF1, P35}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, IL13 (interleukin 13) [NCBI Gene 3596] {aka IL-13, P600}, IL5 (interleukin 5) [NCBI Gene 3567] {aka EDF, IL-5, TRF}, IFNL1 (interferon lambda 1) [NCBI Gene 282618] {aka IL-29, IL29}, IFNA1 (interferon alpha 1) [NCBI Gene 3439] {aka IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA13, IFNA@}, IFNB1 (interferon beta 1) [NCBI Gene 3456] {aka IFB, IFF, IFN-beta, IFNB}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, CTLA4 (cytotoxic T-lymphocyte associated protein 4) [NCBI Gene 1493] {aka ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}, CXCL10 (C-X-C motif chemokine ligand 10) [NCBI Gene 3627] {aka C7, IFI10, INP10, IP-10, SCYB10, crg-2}, IL1RN (interleukin 1 receptor antagonist) [NCBI Gene 3557] {aka CRMO2, DIRA, ICIL-1RA, IL-1RN, IL-1ra, IL-1ra3}, IL15 (interleukin 15) [NCBI Gene 3600] {aka IL-15}, IL18 (interleukin 18) [NCBI Gene 3606] {aka IGIF, IL-18, IL-1g, IL1F4}, CCL5 (C-C motif chemokine ligand 5) [NCBI Gene 6352] {aka D17S136E, RANTES, SCYA5, SIS-delta, SISd, TCP228}, CCL3 (C-C motif chemokine ligand 3) [NCBI Gene 6348] {aka G0S19-1, LD78, LD78ALPHA, MIP-1-alpha, MIP1A, SCI}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, RIGI (RNA sensor RIG-I) [NCBI Gene 23586] {aka DDX58, RIG-I, RIG1, RLR-1, SGMRT2}, IFIH1 (interferon induced with helicase C domain 1) [NCBI Gene 64135] {aka AGS7, Hlcd, IDDM19, IMD95, MDA-5, MDA5}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, ISG15 (ISG15 ubiquitin like modifier) [NCBI Gene 9636] {aka G1P2, IFI15, IMD38, IP17, UCRP, hUCRP}, CD38 (CD38 molecule) [NCBI Gene 952] {aka ADPRC 1, ADPRC1, cADPR1}, CCL2 (C-C motif chemokine ligand 2) [NCBI Gene 6347] {aka GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1}
- **Diseases:** coronary artery disease (MESH:D003324), wheezing (MESH:D012135), long COVID (MESH:D000094024), chronic (MESH:D002908), tissue (MESH:D017695), viral infection (MESH:D014777), death (MESH:D003643), immunodeficiency (MESH:D007153), hypertension (MESH:D006973), osteoporosis (MESH:D010024), COVID-19 (MESH:D000086382), immune dysfunction (MESH:D007154), infection (MESH:D007239), chronic obstructive pulmonary disease (MESH:D029424), obesity (MESH:D009765), autoimmune diseases (MESH:D001327), Respiratory viruses (MESH:D012131), ARDS (MESH:D012128), influenza (MESH:D007251), airway inflammation (MESH:D007249), injury to (MESH:D014947), respiratory infections (MESH:D012141), Chronic inflammatory cytokines (MESH:D020277), asthma (MESH:D001249), cancer (MESH:D009369), diabetes (MESH:D003920)
- **Chemicals:** L-glutamine (MESH:D005973), CO2 (MESH:D002245), HEPES (MESH:D006531), penicillin (MESH:D010406), PBS (-), streptomycin (MESH:D013307)
- **Species:** Influenza A virus (no rank) [taxon 11320], Respiratory syncytial virus (no rank) [taxon 12814], Homo sapiens (human, species) [taxon 9606], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049], H1N1 subtype (serotype) [taxon 114727]

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12943484/full.md

---
Source: https://tomesphere.com/paper/PMC12943484